Liposomes pp 461-472 | Cite as

Complexation of siRNA and pDNA with Cationic Liposomes: The Important Aspects in Lipoplex Preparation

  • José Mario Barichello
  • Tatsuhiro Ishida
  • Hiroshi Kiwada
Part of the Methods in Molecular Biology book series (MIMB, volume 605)


In the last two decades, cationic liposomes have been investigated as vehicles for nucleic acids [plasmid DNA (pDNA) and small interfering RNA (siRNA)] delivery in vitro and in vivo. The formation of cationic liposomes–nucleic acids complexes, termed lipoplexes, depends on a number of experimental variables. The quality of the nucleic acid and the cationic liposome as well as the selection of diluents for diluting the concentrated stocks strongly affect the resulting lipoplexes and their efficiency of gene-expression or gene-silencing effect following transfection. In addition, the molar ratio of cationic lipid nitrogen (N) to siRNA or pDNA phosphate (P) (N/P ratio) influences the final characteristics of the lipoplexes, such as size, surface zeta potential, and reproducibility, thereby reflecting their efficiency following transfection. The methods presented in this chapter could be helpful to obtain reliable and reproducible lipoplexes and experimental results.

Key words

Cationic liposome siRNA pDNA Complex formation siRNA-lipoplex pDNA-lipoplex N/P ratio Lipoplex formation under vortex-mixing Spontaneous lipoplex formation 



The research was supported in part by the Health and Labour Sciences Research Grants for Research on Advanced Medical Technology from The Ministry of Health, Labour and Welfare of Japan. We thank the Japan Association for the Advancement of Medical Equipment for supporting the Postdoctoral Fellowship for Dr. Jose Mario Barichello.


  1. 1.
    Templeton NS, Lasic DD, Frederik PM, Strey HH, Roberts DD, Pavlakis GN (1997) Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol 15:647–652CrossRefPubMedGoogle Scholar
  2. 2.
    Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498CrossRefPubMedGoogle Scholar
  3. 3.
    Dass CR, Choong PF (2006) Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability. J Control Release 113:155–163CrossRefPubMedGoogle Scholar
  4. 4.
    Zhang S, Zhao B, Jiang H, Wang B, Ma B (2007) Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release 123:1–10CrossRefPubMedGoogle Scholar
  5. 5.
    Garcia-Chaumont C, Seksek O, Grzybowska J, Borowski E, Bolard J (2000) Delivery systems for antisense oligonucleotides. Pharmacol Ther 87:255–277CrossRefPubMedGoogle Scholar
  6. 6.
    Lasic DD, Templeton NS (1996) Liposome in gene therapy. Adv Drug Deliv Rev 20:221–266CrossRefGoogle Scholar
  7. 7.
    Lima MCP, Simoes S, Pires P, Faneca H, Duzgunes N (2001) Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. Adv Drug Deliv Rev 47:277–294CrossRefGoogle Scholar
  8. 8.
    Felgner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, Border R et al (1994) Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 269:2550–2561PubMedGoogle Scholar
  9. 9.
    Sternberg B, Hong K, Zheng W, Papahadjopoulos D (1998) Ultrastructural characterization of cationic liposome-DNA complexes showing enhanced stability in serum and high transfection activity in vivo. Biochim Biophys Acta 1375:23–35CrossRefPubMedGoogle Scholar
  10. 10.
    Li CX, Parker A, Menocal E, Xiang S, Borodyansky L, Fruehauf JH (2006) Delivery of RNA interference. Cell Cycle 5:2103–2109CrossRefPubMedGoogle Scholar
  11. 11.
    Spagnou S, Miller AD, Keller M (2004) Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry 43:13348–13356CrossRefPubMedGoogle Scholar
  12. 12.
    Li W, Ishida T, Tachibana R, Almofti MR, Wang X, Kiwada H (2004) Cell type-specific gene expression, mediated by TFL-3, a cationic liposomal vector, is controlled by a post-transcription process of delivered plasmid DNA. Int J Pharm 276:67–74CrossRefPubMedGoogle Scholar
  13. 13.
    Almofti MR, Harashima H, Shinohara Y, Almofti A, Li W, Kiwada H (2003) Lipoplex size determines lipofection efficiency with or without serum. Mol Membr Biol 20:35–43CrossRefPubMedGoogle Scholar
  14. 14.
    Hirsch-Lerner D, Zhang M, Eliyahu H, Ferrari ME, Wheeler CJ, Barenholz Y (2005) Effect of “helper lipid” on lipoplex electrostatics. Biochim Biophys Acta 1714:71–84CrossRefPubMedGoogle Scholar
  15. 15.
    Hofland HEJ, Shephard L, Sullivan SM (1996) Formation of stable cationic lipid/DNA complexes for gene transfer. Proc Natl Acad Sci USA 93:7305–7309CrossRefPubMedGoogle Scholar
  16. 16.
    Boussif O, Lezoualc’h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr J-P (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimide. Proc Natl Acad Sci USA 92:7297–7301CrossRefPubMedGoogle Scholar
  17. 17.
    Doyle SR, Chan CK (2007) Differential intracellular distribution of DNA complexed with polyethylenimine (PEI) and PEI-polyarginine PTD influences exogenous gene expression within live COS-7 cells. Genet Vaccines Ther 5:11CrossRefPubMedGoogle Scholar
  18. 18.
    Lleres D, Weibel JM, Heissler D, Zuber G, Duportail G, Mely Y (2004) Dependence of the cellular internalization and transfection efficiency on the structure and physicochemical properties of cationic detergent/DNA/liposomes. J Gene Med 6:415–428CrossRefPubMedGoogle Scholar
  19. 19.
    Zuidam NJ, Hirsch-Lerner D, Margulies S, Barenholz Y (1999) Lamellarity of cationic liposomes and mode of preparation of lipoplexes affect transfection efficiency. Biochim Biophys Acta 1419:207–220CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • José Mario Barichello
    • 1
  • Tatsuhiro Ishida
    • 1
  • Hiroshi Kiwada
    • 1
  1. 1.Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Institute of Health BiosciencesThe University of TokushimaTokushimaJapan

Personalised recommendations